• Cronos Group completed its acquisition of CanAdelaar for a base price of €57.5 million, subject to closing and post-closing adjustments.
• Additional cash payments will equal 0.5 times CanAdelaar's Normalized EBITDA in each of 2026 and 2027.
• The acquisition establishes a European operating platform through the market leader in the Netherlands' adult-use cannabis pilot program.
• The base price represents approximately 1.4 times net revenue and 2.9 times adjusted EBITDA, based on annualized first-half 2026 results.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cronos Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610150700PRIMZONEFULLFEED9846285) on October 15, 2026, and is solely responsible for the information contained therein.